L11 Drug Discovery and Clinical Trials Flashcards

(35 cards)

1
Q

What are the three broad processes in the pathway to a new drug?

A
  1. Drug discovery
  2. Pre-clinical development
  3. Clinical development
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the 4 major aspects of the drug discovery process?

A
  1. Disease characterization
  2. Target selection and identification of drug hits
  3. Lead optimization
  4. Pharmacological profiling
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the 3 major aspects of pre-clinical development?

A
  1. In-vitro and in-vivo animal models
  2. Pharmacokinetics and toxicology
  3. Formulation and synthesis scale up
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the 3 major aspects of clinical development?

A
  1. Clinical trials
  2. Safety and efficacy
  3. Pharmacokinetics and toxicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the two possible approaches to the drug discovery process?

A
  1. Compound-centered

2. Target-centered

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the compound-centered approach?

A

Take a compound with interesting activity/chemistry and screen biological systems for interesting biological functional effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the target-centered approach?

A

Identify a protein target with known disease association/activity and screen large chemical libraries to identify drug hits that interact with the target and modify activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What happens in lead optimization?

A

A new drug lead is identified; it may not exhibit ideal drug properties. Chemically-modified variants are developed and screened for an increased pharmacological profile.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the outcome of the lead optimization process?

A

New Chemical Entity (NCE)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

After a new drug lead is optimized, what happens?

A

It is tested for efficacy in pre-clinical animal and cellular models of disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the primary role of the CDER?

A

Ensure all prescription and OTC drugs are safe and effective; review all applications for new and generic drugs; monitor compliance with good manufacturing practice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the process of a drug candidate becoming an approved new drug.

A
  1. Investigational New Drug (IND) application
  2. FDA IND review/IRB review
  3. Clinical trial phase I, II, III
  4. NDA
  5. FDA NDA Review
  6. New drug
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What provides exemption from the federal law that only approved drugs may be shipped across state lines?

A

Investigational New Drug (IND) Application

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the three types of investigational new drug application (IND)?

A
  1. Investigator: study an unapproved drug/approved drug for new indication or some other change
  2. Emergency use: authorizes an experimental drug for a single patient with a serious condition
  3. Treatment: allows promising experimental drugs not yet approved to be used in patients with serious conditions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is a set of conditions that must be met in order to participate in a clinical trial?

A

Inclusion critera

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are standards used to determine whether a person may or may not participate in a trial?

A

Exclusion criteria

17
Q

What is the gold standard trial for causality?

A

Randomized controlled clinical trial

18
Q

What is something not directly related to the endpoint that can influence the outcome?

19
Q

What is a trial where both physician and patient know which treatment is administered?

20
Q

What is a trial designed to demonstrate that one treatment is clinically better to either the placebo or another drug?

A

Superiority trial

21
Q

What is a trial designed to demonstrate that one drug is not appreciably less effective than the standard therapy?

A

Non-inferiority trial

22
Q

What is done in a crossover study?

A

Alternating period of administration of placebo and test drug; reduces problems with confounders

23
Q

Describe the number and type of volunteer, the questions asked, and the length of time for a Phase I clinical trial.

A
  1. 20-100 healthy volunteers
  2. Is it safe and tolerable? What are the pharmacokinetic parameters?
  3. Months
24
Q

Describe the number and type of volunteer, the questions asked, and the length of time for a Phase II clinical trial.

A
  1. 100-200 patients
  2. Does it work in patients? What is the appropriate dosing?
  3. 1-2 years
25
Describe the number and type of volunteer, the questions asked, and the length of time for a Phase III clinical trial.
1. 1000-6000 patients 2. Does it work in large patient populations? 3. 3-5 years
26
What happens after Phase III trials?
Regulatory approval
27
What is Phase IV?
Post-marketing surveillance for adverse effects, interactions, and complications
28
What happens after the completion of Phase II trials?
FDA meets with the drug sponsor to establish the safety of proceeding with Phase III
29
When does a drug withdrawal happen?
Unacceptable toxicity or new adverse reactions; manufacturer agrees to cease marketing
30
What is a drug recall?
Temporary removal of a drug from the market
31
What is a Class I recall?
Reasonable probability that use of drug will cause serious health consequences of death
32
What is a Class II recall?
Use of drug will cause temporary adverse health conditions, although probability of serious health consequences is remote
33
What is a Class III recall?
Use of drug is unlikely to cause adverse health consequences
34
How long is patent protection for new drugs?
20 years
35
What is an abbreviated new drug application used for?
Marketing of a generic version of the drug